Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Placenta products might help with hair loss, but more research is needed.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Micropigmentation is a cosmetic tattooing technique for hiding skin issues and creating permanent makeup, but it can have side effects.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Topical minoxidil improved hair loss in a patient when used consistently.

PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Minoxidil and finasteride effectively treat hair loss.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.